Skip to Main Content

Author Details

Alessandro Romanel
University of Trento
2008
48
20
PMIDPaper TitleJournal TitlePublished Year
36484701Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data.Bioinformatics2023
36779822Analysis of Genetic Ancestry from NGS Data Using EthSEQ.Curr Protoc2023
36484701Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data.Bioinformatics2023
36746939LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.Nat Commun2023
36779822Analysis of Genetic Ancestry from NGS Data Using EthSEQ.Curr Protoc2023
36746939LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.Nat Commun2023
34605002Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients.Int J Cancer2022
35970913A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness.Nat Commun2022
35796299Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster.EMBO Rep2022
35061909Polympact: exploring functional relations among common human genetic variants.Nucleic Acids Res2022
35259458ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation.Cancer Lett2022
35253958Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.EMBO Rep2022
34605002Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients.Int J Cancer2022
35199053<i>YES1</i> and <i>MYC</i> Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs.JTO Clin Res Rep2022
35796299Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster.EMBO Rep2022
35970913A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness.Nat Commun2022
35253958Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.EMBO Rep2022
35061909Polympact: exploring functional relations among common human genetic variants.Nucleic Acids Res2022
35199053<i>YES1</i> and <i>MYC</i> Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs.JTO Clin Res Rep2022
35259458ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation.Cancer Lett2022
33293234Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285].Eur Urol Oncol2021
33594971One-shot analysis of translated mammalian lncRNAs with AHARIBO.Elife2021
33293234Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285].Eur Urol Oncol2021
34917903<i>TranSNPs</i>: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance.iScience2021
33594971One-shot analysis of translated mammalian lncRNAs with AHARIBO.Elife2021
34917903<i>TranSNPs</i>: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance.iScience2021
32332823Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.Nat Commun2020
32332823Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.Nat Commun2020
32091413Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.J Clin Invest2020
31922552ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.Bioinformatics2020
33186463Exploring functionally annotated transcriptional consensus regulatory elements with CONREL.Database (Oxford)2020
33288740Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.Cell Death Dis2020
32671985Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.Cancer Rep (Hoboken)2020
32669676Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.Br J Cancer2020
31922552ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.Bioinformatics2020
32091413Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.J Clin Invest2020
33288740Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.Cell Death Dis2020
33186463Exploring functionally annotated transcriptional consensus regulatory elements with CONREL.Database (Oxford)2020
32671985Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.Cancer Rep (Hoboken)2020
32669676Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.Br J Cancer2020
30378073Allele-Specific Expression Analysis in Cancer Using Next-Generation Sequencing Data.Methods Mol Biol2019
31851932Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma.Cell Rep2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
31878881PaCBAM: fast and scalable processing of whole exome and targeted sequencing data.BMC Genomics2019
30257982RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2019
30378073Allele-Specific Expression Analysis in Cancer Using Next-Generation Sequencing Data.Methods Mol Biol2019
30232224A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.Clin Cancer Res2019
31138260Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.J Exp Clin Cancer Res2019
31200842Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations.Eur Urol Oncol2019
31851932Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma.Cell Rep2019
  • 1 - 50 of 96

Recommended Authors

Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 0
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 1
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 1
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 0
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 2
Sebastian M Waszak
University of California san francisco
Career Start Year 2010
Number of shared co-authors 2
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2009
Number of shared co-authors 0
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 6
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 1
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 1
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 3
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 10
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
Joachim Weischenfeldt
University of Copenhagen
Career Start Year 2004
Number of shared co-authors 6
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 1
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 2
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 2
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 19
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Peter J Park
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 14
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 12
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 0
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 18

Collaborators

Francesca Demichelis
University of Trento
Co-authored papers 29
Mark A Rubin
University of Bern
Co-authored papers 12
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 12
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 10
Davide Prandi
University of Trento
Co-authored papers 9
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 9
Olivier Elemento
Meyer Cancer Center
Co-authored papers 9
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 6
Christopher E Barbieri
Weill Cornell Medical College
Co-authored papers 5
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 4
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Co-authored papers 4
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers 4
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 4
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 4
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 4
Robert Kim
University of California
Co-authored papers 3
Sylvan C Baca
Co-authored papers 3
Hanna Rennert
New York NewYork-Presbyterian Hospital
Co-authored papers 3
Tuo Zhang
Weill Cornell Medical College.
Co-authored papers 3
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 3
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 3
David S Rickman
Meyer Cancer Center
Co-authored papers 3
Kenneth Eng
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
Kyung Park
New York University Langone Health
Co-authored papers 3
Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 2
Noah Greco
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Susana Miranda
The Institute of Cancer Research
Co-authored papers 2
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 2
Release 1.2